X4 Pharmaceuticals(XFOR) - 2023 Q3 - Quarterly Report
X4 Pharmaceuticals(XFOR)2023-11-09 22:11UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 _____________________________________________________________________________________ FORM 10-Q _____________________________________________________________________________________ (Mark One) (Exact name of registrant as specified in its charter) _____________________________________________________________________________________ ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterl ...